Status:
TERMINATED
Recording and Modulation of Brain Activity Through Chronically Implanted Stimulation Electrodes
Lead Sponsor:
Jocelyne Bloch
Collaborating Sponsors:
Hôpital du Valais
Conditions:
Parkinson Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
For decades, deep brain stimulation (DBS) therapies have been employed very successfully to alleviate segmental motor symptoms (tremor, brady-kinesia or rigidity) in patients with Parkinson's disease ...
Detailed Description
This project seeks to leverage the latest technological innovations for monitoring and modulating motor and neural states chronically, in order to comprehensively characterize gait deficits in PD, and...
Eligibility Criteria
Inclusion
- Age: 18 years old or more
- Informed Consent as documented by signature
- Diagnosed with Parkinson's disease, and being treated with deep brain stimulation therapies.
- Exhibiting severe locomotor deficits
- Agree to comply in good faith with all conditions of the recordings.
Exclusion
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- Participation in another investigational study in the preceding 30 days
- Previous enrolment into the current study
Key Trial Info
Start Date :
October 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 6 2023
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04703556
Start Date
October 4 2021
End Date
July 6 2023
Last Update
September 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire Vaudois
Lausanne, Canton of Vaud, Switzerland, 1011